# Novacyl Wuxi Pharmaceutical Co., Ltd. – FDA Inspection, Sep 15, 2017

Source: https://www.keypedia.com/records/fda_inspections/novacyl-wuxi-pharmaceutical-co-ltd/1379cff2-3803-4f69-9cda-c9212000a332
Source feed: FDA_Inspections

> FDA inspection 1029764 of Novacyl Wuxi Pharmaceutical Co., Ltd., September 15, 2017. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1029764
- Company Name: Novacyl Wuxi Pharmaceutical Co., Ltd.
- Inspection Date: 2017-09-15
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- [FDA Inspection 965700 - 2016-04-14](https://www.keypedia.com/records/fda_inspections/novacyl-wuxi-pharmaceutical-co-ltd/2229d702-8259-41c1-a77d-0cff43730a0f)
- [FDA Inspection 853505 - 2013-10-18](https://www.keypedia.com/records/fda_inspections/novacyl-wuxi-pharmaceutical-co-ltd/c61ca5ce-1363-4c25-b082-421ccc50aa4c)
- FDA Inspection 735469 - 2011-04-21

## Related Officers

- [Arsen Karapetyan](https://www.keypedia.com/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)

Company: https://www.keypedia.com/companies/novacyl-wuxi-pharmaceutical-co-ltd/df90cc11-f2af-4bb7-bf70-f32a8bcc4fb8

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8